<?xml version="1.0" encoding="UTF-8"?>
<ack>
 <title>Acknowledgements</title>
 <p>We like to acknowledge, with thanks, the very valuable contributions to this study made by Susan Beardslee and Don Johns of Genzyme, as well as from those investigators, Auayporn Nadamanee, Patrick Stiff, Han Myint, Luciano Costa, Stephanie Elkins and Jason Tay, who also actively participated in this study. Editorial support in the preparation of this publication was provided by Helen Varley, PhD, CMPP, Barrie Anthony PhD, CMPP, and John Clarke, PhD, of Envision Scientific Solutions, Horsham, UK, funded by Sanofi. ClinicalTrials.gov Identifier: NCT01164475</p>
 <sec id="FPar1">
  <title>Funding</title>
  <p id="Par27">The study was sponsored by Sanofi, Cambridge, Massachusetts, USA, to fulfill NDA 22-311 post-marketing commitment #5. Editorial support in the preparation of this publication was funded by Sanofi. We, individually and collectively, are responsible for all content and editorial decisions and received no payment from Sanofi directly or indirectly (through a third party) related to the development/presentation of this publication.</p>
 </sec>
 <sec id="FPar2">
  <title>Authors contributions</title>
  <p id="Par28">J.K. was the study principal investigator and principal author. C.-H.T., S.-G.C., S.J.K., J.-L.T. were involved in clinical accrual and manuscript development and review. P.C. was the clinical lead and author, along with J.W., statistics, Y.S., pharmacokinetics, and R.V., clinical trial management; these individuals were the sponsor responsible persons for data analysis and provided substantial contribution to authorship. All authors had full access to the data and reviewed and edited the manuscript before submission.</p>
 </sec>
</ack>
